EUVIMEDDescoperă EUVIMED
Crossref

How incretin-based therapies address the spectrum of physiologic disturbance in type 2 diabetes

The Internet Journal of Academic Physician Assistants · 2010

DOI: 10.5580/172c ↗

At a glance

Journal article in The Internet Journal of Academic Physician Assistants, 2010.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Blood glucose-lowering agents that exert their therapeutic effect through the incretin hormone system are emerging as effective and well-tolerated therapies for type 2 diabetes. Due to their glucose-dependent mode of action these agents are associated with minimal hypoglycemic risk, and do not cause weight gain, thus avoiding limitations associated with many existing treatments that may threaten treatment adherence. Of the two classes of incretin therapies currently available, the GLP-1 receptor agonists have shown the ability to decrease HbA1c to a greater extent than DPP-4 inhibitors, and GLP-1 agonists may also reduce cardiovascular risk through modification of certain known risk factors, including via weight loss. This article explains the rationale behind using incretin-based therapies, summarizes key data from clinical trials of the GLP-1 agonists exenatide and liraglutide, and licensed DPP-4 inhibitors including sitagliptin and saxagliptin, and provides practical guidance on the use of these agents in clinical practice.

Cite

APA

(2010). How incretin-based therapies address the spectrum of physiologic disturbance in type 2 diabetes. The Internet Journal of Academic Physician Assistants. https://doi.org/10.5580/172c

Vancouver

How incretin-based therapies address the spectrum of physiologic disturbance in type 2 diabetes. The Internet Journal of Academic Physician Assistants. 2010. doi:10.5580/172c

BibTeX
@article{euvimed2010,
  title = {How incretin-based therapies address the spectrum of physiologic disturbance in type 2 diabetes},
  journal = {The Internet Journal of Academic Physician Assistants},
  year = {2010},
  doi = {10.5580/172c}
}
Start for free →